Helen I. Torley
Overview
Helen I. Torley received an average of $6M in total compensation, including $705K in salary, at Halozyme Therapeutics from 2014 to 2021.
2021Halozyme TherapeuticsPresident and Chief Executive Officer
2020Halozyme TherapeuticsPresident and Chief Executive Officer
2019Halozyme TherapeuticsPresident and Chief Executive Officer
2018Halozyme TherapeuticsPresident and Chief Executive Officer
2017Halozyme TherapeuticsPresident and Chief Executive Officer
2016Halozyme TherapeuticsPresident and Chief Executive Officer
2015Halozyme TherapeuticsPresident and Chief Executive Officer
2014Halozyme TherapeuticsPresident and Chief Executive Officer
Source: SEC filings on March 25, 2022, March 26, 2021, March 20, 2020, March 22, 2019, March 22, 2018, and March 24, 2017.
Related executives
We found 21 more executives who work or worked at Halozyme Therapeutics.
Masaru Matsuda
Halozyme Therapeutics
General Counsel
Michael LaBarre
Halozyme Therapeutics
Senior Vice President, Chief Technical Officer
Elaine Sun
Halozyme Therapeutics
Chief Financial Officer
Laurie Stelzer
Halozyme Therapeutics
Chief Financial Officer
Alison Armour
Halozyme Therapeutics
Former Senior Vice President, Head of Research & Development
Benjamin Hickey
Halozyme Therapeutics
Former Senior Vice President, Chief Commercial Officer
Harry Leonhardt
Halozyme Therapeutics
General Counsel
Dimitrios Chondros
Halozyme Therapeutics
Chief Medical Officer
News
Halozyme Therapeutics CEO Helen Torley's 2021 pay rises 14% to $7.5M
March 25, 2022
Halozyme Therapeutics CEO Helen Torley's 2020 pay rises 11% to $6.5M
March 26, 2021
Halozyme Therapeutics CEO Helen Torley's 2019 pay rises 1% to $5.9M
March 20, 2020
Halozyme Therapeutics CEO Helen Torley's 2018 pay rises 12% to $5.8M
March 22, 2019